INSM — INSMED Inc
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1104506 ·
Last close
$117.83
Market Cap
$25.73B
52W High
$212.75
52W Low
$90.39
ADV30
1,965,353
Next earnings
2026-10-29
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 425,486,000 | 358,274,000 | -101,308,000 | -13,242,000 | 2,102,565,000 | 544,765,000 | 1,345,071,000 |
| Mar 2026 | 305,964,000 | 258,544,000 | -200,281,000 | -163,563,000 | 2,075,863,000 | 582,188,000 | 1,371,011,000 |
| Dec 2025 | 263,843,000 | 219,623,000 | -249,708,000 | -328,485,000 | 2,264,558,000 | 510,445,000 | 1,525,582,000 |
| Sep 2025 | 142,342,000 | 112,977,000 | -261,352,000 | -370,021,000 | 2,360,736,000 | 334,764,000 | 1,415,165,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-895,664,000
Investing CF
$120,533,000
Financing CF
$954,589,000
CapEx
$-25,971,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-5.75
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-5,813,497,000
Inventory
$142,384,000
Receivables
$215,325,000
ST Investments
$615,547,000
EBIT TTM
$-793,299,000
Pretax Income TTM
$-869,106,000
Interest Exp TTM
$75,807,000
Analysts
22
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,137,634,944
EBITDA
$-794,955,008
Free Cash Flow
$-571,815,616
Enterprise Value
$27,840,161,792
Total Cash
$1,160,312,064
Total Debt
$739,724,032
Shares Out
218,381,503
Trailing EPS
$-4.12
Book Value
$3.47
ROE
-87.2%
ROA
-22.2%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 606,423,000 | -994,776,000 | -1,276,775,000 | 2,264,558,000 | 1,525,582,000 | 738,976,000 | -935,014,000 |
| Dec 2024 | 363,707,000 | -786,570,000 | -913,772,000 | 2,025,231,000 | 1,739,852,000 | 285,379,000 | -683,882,000 |
| Dec 2023 | 305,208,000 | -680,929,000 | -749,567,000 | 1,329,837,000 | 1,661,760,000 | -331,923,000 | -536,247,000 |
| Dec 2022 | 245,358,000 | -478,123,000 | -481,534,000 | 1,656,435,000 | 1,568,484,000 | 87,951,000 | -400,439,000 |
TTM Snapshot
Revenues TTM
$333,050,000
NetIncome TTM
$-767,185,000
OpCashFlow TTM
$0
Assets (Latest)
$2,264,558,000
Forward EPS
$0.74
Max Pain — expiry 2026-11-20
max pain strike: $115.00 · spot: $117.69 · call oi: 12,345 · put oi: 16,364
Expected Move to 2026-11-20:
±$19.60
(16.65%) —
implied range
$98.09 –
$137.29
· ATM straddle on $120.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | $25.86B | $35.80 | — |
| RPRX | Royalty Pharma plc | $25.92B | $58.21 | — |
| ZTS | Zoetis Inc. | $29.36B | $71.05 | — |
| GMAB | GENMAB A/S | $21.72B | $35.32 | — |
| VTRS | Viatris Inc | $20.48B | $17.83 | — |
News headlines (Yahoo Finance, 1h cache)
Did FDA Priority Review of ARIKAYCE ENCORE Data Just Shift Insmed's (INSM) Investment Narrative?
2026-09-21 18:18 · Yahoo
FDA Grants Priority Review to Insmed's sNDA for ARIKAYCE® (amikacin liposome inhalation suspension) for Treatment of MAC Lung Disease With PDUFA Target Action Date Set for January 28, 2027
2026-09-21 11:00 · Yahoo
The Fund Exited Insmed (INSM) After the Investment Thesis Played Out
2026-09-16 14:40 · Yahoo
Insmed Expands Community Impact During Fifth Annual Global Day of Good
2026-09-16 11:00 · Yahoo
Exiting Insmed (INSM) Following Disappointing Key Drug Uptake
2026-09-10 11:52 · Yahoo
Insmed’s (INSM) New Drug Launch Is Reshaping The Whole Business
2026-09-02 08:42 · Yahoo
Insmed to Present at September 2026 Investor Conferences
2026-08-26 11:00 · Yahoo
BRINSUPRI® (brensocatib) Approved by Japan's Ministry of Health, Labour and Welfare for the Treatment of Patients With Non-Cystic Fibrosis Bronchiectasis, a Serious, Chronic Lung Disease
2026-08-24 11:00 · Yahoo
Insmed (INSM) Q2 2026 Earnings Call Transcript
2026-08-13 15:16 · Yahoo
What BioPharma Credit (BPCP) Said on Its H1 Earnings Call
2026-09-25 15:03 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.